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BACKGROUND
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RESULTS

Levalbuterol may be prescribed in place of racemic
albuterol to help decrease the adverse effects thought to be
mediated by the S-enantiomer in racemic albuterol.
✦ Racemic albuterol is a 50:50 mixture of R- and Senantiomers, whereas levalbuterol is only the Renantiomer.
✦ A review of literature shows conflicting results regarding
levalbuterol adverse effects.

✦ An annual drug usage evaluation for levalbuterol 0.625mg and 1.25mg was completed
for the time period of January 1, 2012 through January 31, 2013 across all inpatient
admissions for a 550 bed not-for-profit regional medical center.
✦ The consensus standard of interchange of racemic albuterol for levalbuterol occurs with
a 2:1 ratio (e.g. racemic albuterol 2.5mg for levalbuterol 1.25mg and racemic albuterol
1.25mg for levalbuterol 0.625mg).The cost avoidance for this study was calculated
using this ratio.
✦ The annual cost avoidance of automatically interchanging racemic albuterol in place of
levalbuterol was determined by comparing the purchase costs and usage of
levalbuterol 0.625mg and 1.25mg against the purchase costs of racemic albuterol
1.25mg and 2.5mg.
✦ The cost avoidance at interchange rates between 70% through 100% was calculated.

✦ There was a total of 15096 units of levalbuterol 0.625mg used
in this time period which yielded an annual spending of $49816
✦ There was a total of 17214 units of levalbuterol 1.25mg used in
this time period that yielded an annual spending of $68823.
✦ An interchange rate of 70% to 100% could yield a cost
avoidance in the range of $71186 to $101695 annually.
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Levalbuterol costs 3.5 to 25 times more than racemic
albuterol.
The range of cost avoidance using an automatic therapeutic
interchange of racemic albuterol for levalbuterol can vary.
Various health system pharmacies utilize different
interchange rates
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✦ Depending on the annual rate of conversion, the automatic
therapeutic interchange of racemic albuterol in place of
levalbuterol can yield an annual cost avoidance from $71186
to $101695,
✦ A protocol for automatic therapeutic interchange of racemic
albuterol for levalbuterol can offer substantial savings, even
at interchange rates of less than 100%.
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